IIM Indore will organize ‘Stem Cell Donation’ camp on 03 March 2017 on its campus. The programme will be organized by the Ranbhoomi team of 2017 in association with Genebandhu. Genebandhu is an Indian stem cell registry and an NGO. This NGO aims to eradicate diseases such as Leukemia, Aplastic Anemia, Thalassemia, Sickle-cell Anemia, etc. All these diseases lead to death of a person because of lack of a matched unrelated donor (MUD). Therefore, in 2017 team ‘Ranbhoomi’ and GeneBandhu will work in collaboration with each other for the betterment of the humanity. With support of Team Ranbhoomi, Genebandhu will get closer to their vision of minimizing the time required for a person to find a Stem Cell match and also ensure a successful donation.
Genebandhu came forward to organize camps so that few of these patients can live and their hopeful wait ends. It is for the first time that Genebandhu has decided to come forward with this creative idea to interact with the youth and also spread awareness about these fatal diseases. Genebandhu doctors would also be attending the camp.
At IIM Indore, Ranbhoomi’2017 would be held from March 3 to 5, 2017. The event will witness presence of Rio 2016 Paralympics gold medallist Mariappan Thangavelu and Asian Para Games 2014 gold medallist Sharad Kumar. The event aims to help iHelp’s cause as a part of our social initiative.
For more information you can visit the official website of IIM Indore.
About IIM Indore
IIM Indore offers Post Graduate Programme in Management (PGP) by selecting MBA Aspirants through CAT Exam which is conducted annually. The PGP issued by the Indian Institute of Management Indore is recognized by Association of Indian Universities (AIU) as equivalent to M.B.A. Degree of an Indian University. IIM Indore has 86 well-qualified internal faculty along with adjunct faculty with considerable industry expertise
For more updates on MBA related News, keep visiting MBA section of Jagranjosh.com
Latest Updates on IIMs
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.